Ginkgo Bioworks Holdings, Inc. (BMV:DNA)

Market Cap	9.16B +7.9%
Revenue (ttm)	2.73B -33.4%
Net Income	-5.49B
EPS	-96.63
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	53
Average Volume	320
Open	150.00
Previous Close	n/a
Day's Range	150.00 - 150.00
52-Week Range	150.00 - 289.00
Beta	n/a
RSI	29.20
Earnings Date	Aug 6, 2026

About Ginkgo Bioworks Holdings

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops a platform for cell engineering in the United States. It operates through the Cell Engineering and Biosecurity segments. The company offers cell engineering research and development solutions, as well as cell engineering tools comprising functional genomics, antibody developability, and small molecule developability, artificial intelligence models, and reconfigurable automation cart systems on its platform for use in the research, development, and commercialization of engi...

• Founded: 2008
• Employees: 485
• Stock Exchange: Mexican Stock Exchange
• Ticker Symbol: DNA

Financial Performance

In 2025, Ginkgo Bioworks Holdings's revenue was $170.16 million, a decrease of -25.06% compared to the previous year's $227.04 million. Losses were -$312.76 million, -42.83% less than in 2024.

Financial numbers in USD